Follow
Nicole L Votaw
Nicole L Votaw
Isolere Bio, Inc
Verified email at isolerebio.com
Title
Cited by
Cited by
Year
Biomaterial strategies for generating therapeutic immune responses
SH Kelly, LS Shores, NL Votaw, JH Collier
Advanced drug delivery reviews 114, 3-18, 2017
642017
Controlled Lengthwise Assembly of Helical Peptide Nanofibers to Modulate CD8+ T‐Cell Responses
CN Fries, Y Wu, SH Kelly, M Wolf, NL Votaw, S Zauscher, JH Collier
Advanced Materials 32 (39), 2003310, 2020
332020
Randomized peptide assemblies for enhancing immune responses to nanomaterials
NL Votaw, L Collier, EJ Curvino, Y Wu, CN Fries, MT Ojeda, JH Collier
Biomaterials 273, 120825, 2021
212021
Modular complement assemblies for mitigating inflammatory conditions
KM Hainline, LS Shores, NL Votaw, ZJ Bernstein, SH Kelly, CN Fries, ...
Proceedings of the National Academy of Sciences 118 (15), e2018627118, 2021
202021
HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth
CN Fries, JL Chen, ML Dennis, NL Votaw, J Eudailey, BE Watts, ...
Scientific Reports 11 (1), 14494, 2021
142021
A sublingual nanofiber vaccine to prevent urinary tract infections
SH Kelly, NL Votaw, BJ Cossette, Y Wu, S Shetty, LS Shores, LA Issah, ...
Science Advances 8 (47), eabq4120, 2022
132022
Helical Peptide Nanofibers: Controlled Lengthwise Assembly of Helical Peptide Nanofibers to Modulate CD8+ T‐Cell Responses (Adv. Mater. 39/2020)
CN Fries, Y Wu, SH Kelly, M Wolf, NL Votaw, S Zauscher, JH Collier
Advanced Materials 32 (39), 2070295, 2020
22020
Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres
EJ Curvino, EF Roe, H Freire Haddad, AR Anderson, ME Woodruff, ...
Nature Biomedical Engineering, 1-22, 2023
12023
Polysequence Nanomaterials for Immunomodulation
NL Votaw
Duke University, 2021
2021
Supramolecular polypeptide compositions and methods of making and using the same
J Collier, N Votaw
2020
The system can't perform the operation now. Try again later.
Articles 1–10